Overview
Financials
Filing timeliness
The financial statement for 2025 was filed on time.
- 202530/03/2026
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, one member of the company’s management board is authorized to make declarations of will on behalf of the company independently. In the case of a multi-member management board, where no Vice-President of the Management Board of the company has been appointed, each member of the company’s management board is authorized to make declarations of will on behalf of the company independently. In the case of a multi-member management board, where a Vice-President of the Management Board of the company has been appointed, joint action by a member of the company’s management board together with the Vice-President of the Management Board of the company is required to make declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jan Jerzy Guzowskiage 44 | 145 | $1,958.40 | 39.1892% |
Instytut Chemii Fizycznej Polskiej Akademii Nauk | 80 | $1,080.50 | 21.6216% |
Katarzyna Olga Rojekage 38 | 145 | $1,958.40 | 39.1892% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2026-04-01.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $288,782.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 26, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $18,750$18,750 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Mar 16, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $53,863$53,863 | Podkarpackie Centrum Innowacji sp. z o.o. | |
| Feb 20, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $35,047$35,047 | OIC Poland Fundacja Akademii Wsei |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2026-01-01 | Preparation of an application for a Eurogrant planned under the EIC Advanced Innovation Challenges - Translating Disruptive New Approach Methodologies (NAMs) into Practice programme | $18,750$18,750 | European Funds for a Modern Economy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
Last updated: 2026-03-31